Report on illicit drug use and overdoses by members of the Armed Forces serving on active duty

Not later than December 1, 2023, the Secretary of Defense shall submit to the Committees on Armed Services of the Senate and House of Representatives a report regarding illicit drug use by members of the Armed Forces serving on active duty, and monitoring and prevention systems within the Department of Defense regarding such use. The report shall include the following elements: (1)The number of instances of such drug use and overdoses among such members during the calendar year preceding the date of the report. (2)The number of instances described in paragraph (1) that were related to fentanyl. (3)An explanation of how the Secretary uses urinalysis and other tests to monitor such use, and an assessment of the efficacy of such tests. (4)The extent to which fentanyl has contributed to such overdoses when combined with other, less deadly substances. (5)The policies of the Department designed to prevent retaliation against such members who seek treatment or inform a commanding officer of their illicit drug use. (6)Demographic data and ranks of such members who suffered a fentanyl overdose. (7)Shortcomings (including strategic or budgetary) identified by the Secretary of the counternarcotics programs of the Department regarding military installations. (8)A thorough review of the support and treatment options offered to such a member who reports addiction or illicit drug use, including— (A)any wait time before receiving care; and (B)the type of care offered across each Armed Force. (9)Any other matter the Secretary determines appropriate.